Expiratory Muscle Strength Training for Therapy of Pharyngeal Dysphagia in Parkinson's Disease.

Swallowing problems are common in Parkinson's disease and can lead to poor nutrition and lung infections from food or liquid entering the airway, yet there are few proven behavioral treatments. This trial looked at whether four weeks of expiratory muscle strength training, which involves breathing exercises against resistance to strengthen the muscles used in coughing and swallowing, could improve swallowing function. Fifty patients with confirmed swallowing difficulty were randomly assigned to use either a calibrated resistance device or a sham device that looked the same but provided no real training effect. Patients using the real device showed a statistically significant improvement in swallowing scores after four weeks, with the benefit still present three months later, while those using the sham device showed no significant change.

The improvement was mainly seen in reduced pharyngeal residue, meaning less food left behind in the throat after swallowing. Brain imaging found no measurable change in swallowing-related brain activity, suggesting the benefit came from muscle-level changes rather than the brain relearning the task. The trial was reasonably sized but still modest, and longer-term outcomes beyond three months were not reported.

If you or someone you know has Parkinson's disease, you may already know that swallowing difficulties are a frequent and worrying part of the condition, sometimes leading to poor nutrition or chest infections from food going down the wrong way. Researchers wanted to see whether a specific breathing exercise, done with a device that adds resistance to exhaling, could help strengthen the muscles involved in swallowing. In this study, fifty people with Parkinson's-related swallowing problems were split into two groups.

One group used a real resistance device for four weeks, while the other used a device that looked identical but did not provide the same training effect. People using the real device showed a meaningful improvement in how well they swallowed, particularly less leftover food remaining in the throat, and this improvement lasted for at least three months.

The group using the fake device did not show this improvement. Brain scans did not show changes in the swallowing control centers, suggesting the benefit came from stronger muscles rather than changes in the brain. This was a modest-sized trial, so while the results are encouraging, they represent one study rather than a large body of evidence.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This double-blind, randomized, controlled trial evaluated four weeks of expiratory muscle strength training in 50 patients with hypokinetic pharyngeal dysphagia secondary to Parkinson's disease, confirmed via flexible endoscopic evaluation of swallowing (FEES). Participants were allocated to a calibrated active device (n=25) or a sham handheld device (n=25), with swallowing function reassessed post-training and at three-month follow-up.

The active group demonstrated a statistically significant reduction in FEES-based dysphagia severity scores at both time points, whereas the sham group showed no significant change from baseline, indicating a between-group difference favoring active training with a sustained effect over the follow-up period. The improvement was driven largely by reduced pharyngeal residue, pointing to enhanced swallowing efficiency rather than changes in airway protection specifically. A magnetoencephalography substudy in 22 participants (11 active, 11 sham) found no statistically significant differences in cortical swallowing network activation pre- versus post-training, suggesting the therapeutic mechanism is more likely peripheral (muscular) than central (cortical reorganization). While the randomized, sham-controlled design and blinding strengthen confidence in the observed effect, the sample size remains modest for a condition with heterogeneous presentation, and longer-term durability beyond three months was not assessed.

No adverse events were reported in the abstract.